Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism.
Mandriota SJ, Valentijn LJ, Lesne L, Betts DR, Marino D, Boudal-Khoshbeen M, London WB, Rougemont AL, Attiyeh EF, Maris JM, Hogarty MD, Koster J, Molenaar JJ, Versteeg R, Ansari M, Gumy-Pause F.
Mandriota SJ, et al. Among authors: koster j.
Oncotarget. 2015 Jul 30;6(21):18558-76. doi: 10.18632/oncotarget.4061.
Oncotarget. 2015.
PMID: 26053094
Free PMC article.